Advances in the Discovery of Small Molecule JAK3 Inhibitors

被引：21

作者：

Wrobleski, Stephen T. ^{[1
]}

Pitts, William J. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, R&D, Princeton, NJ 08543 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44 | 2009年 / 44卷

关键词：

JANUS KINASE 3; ALLOGRAFT-REJECTION; CP-690,550; DOMAIN; DEFICIENCY; RECIPIENTS;

D O I：

10.1016/S0065-7743(09)04412-1

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：247 / 264

页数：18

共 61 条

[1] Characterization and analysis of the proximal Janus kinase 3 promoter [J].

Aringer, M ;

Hofmann, SR ;

Frucht, DM ;

Chen, M ;

Centola, M ;

Morinobu, A ;

Visconti, R ;

Kastner, DL ;

Smolen, JS ;

O'Shea, JJ .

JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :6057-6064

[2] Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog [J].

Boggon, TJ ;

Li, YQ ;

Manley, PW ;

Eck, MJ .

BLOOD, 2005, 106 (03) :996-1002

[3] Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates [J].

Borie, DC ;

Larson, MJ ;

Flores, MG ;

Campbell, A ;

Rousvoal, G ;

Zhang, S ;

Higgins, JP ;

Ball, DJ ;

Kudlacz, EM ;

Brissette, WH ;

Elliott, EA ;

Reitz, BA ;

Changelian, PS .

TRANSPLANTATION, 2005, 80 (12) :1756-1764

[4]

Bourke D. G., 2008, WO, Patent No. [2008092199A1, 2008092199]

[5]

Brain C. T., 2007, World patent, Patent No. 2007140222

[6] Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].

Changelian, PS ;

Flanagan, ME ;

Ball, DJ ;

Kent, CR ;

Magnuson, KS ;

Martin, WH ;

Rizzuti, BJ ;

Sawyer, PS ;

Perry, BD ;

Brissette, WH ;

McCurdy, SP ;

Kudlacz, EM ;

Conklyn, MJ ;

Elliott, EA ;

Koslov, ER ;

Fisher, MB ;

Strelevitz, TJ ;

Yoon, K ;

Whipple, DA ;

Sun, JM ;

Munchhof, MJ ;

Doty, JL ;

Casavant, JM ;

Blumenkopf, TA ;

Hines, M ;

Brown, MF ;

Lillie, BM ;

Subramanyam, C ;

Shang-Poa, C ;

Milici, AJ ;

Beckius, GE ;

Moyer, JD ;

Su, CY ;

Woodworth, TG ;

Gaweco, AS ;

Beals, CR ;

Littman, BH ;

Fisher, DA ;

Smith, JF ;

Zagouras, P ;

Magna, HA ;

Saltarelli, MJ ;

Johnson, KS ;

Nelms, LF ;

Des Etages, SG ;

Hayes, LS ;

Kawabata, TT ;

Finco-Kent, D ;

Baker, DL ;

Larson, M .

SCIENCE, 2003, 302 (5646) :875-878

[7]

CHANGELIAN PS, 2008, Patent No. 2008029237

[8] Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach [J].

Chen, Xin ;

Wilson, Lawrence J. ;

Malaviya, Ravi ;

Argentieri, Rochelle L. ;

Yang, Shyh-Ming .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) :7015-7019

[9] Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3) [J].

Clark, Michael P. ;

George, Kelly M. ;

Bookland, Roger G. ;

Chen, Jack ;

Laughlin, Steven K. ;

Thakur, Kumar D. ;

Lee, Wenlin ;

Davis, Jan R. ;

Cabrera, Ed J. ;

Brugel, Todd A. ;

VanRens, John C. ;

Laufersweiler, Matthew J. ;

Maier, Jennifer A. ;

Sabat, Mark P. ;

Golebiowski, Adam ;

Easwaran, Vijay ;

Webster, Mark E. ;

De, Biswanath ;

Zhang, George .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) :1250-1253

[10] Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection [J].

Deuse, Tobias ;

Velotta, Jeffrey B. ;

Hoyt, Grant ;

Govaert, Johannes A. ;

Taylor, Vanessa ;

Masuda, Esteban ;

Herlaar, Ellen ;

Park, Gary ;

Carroll, David ;

Pelletier, Marc P. ;

Robbins, Robert C. ;

Schrepfer, Sonja .

TRANSPLANTATION, 2008, 85 (06) :885-892

← 1 2 3 4 5 6 7 →